Tretinoin Pharmaceutical Overview
Retino A 0.05% Cream is a tretinoin-based pharmaceutical preparation manufactured by Johnson & Johnson for laboratory research examining retinoid receptor interactions and cellular differentiation pathways. This topical formulation contains 0.05% tretinoin in a standardised pharmaceutical base, providing researchers with a well-characterised reference compound for investigating vitamin A derivative mechanisms. As a derivative of retinoic acid, tretinoin serves as a valuable tool for studying nuclear receptor signalling and gene expression modulation in cellular research models. Research teams at Stroid UK Shop utilise this pharmaceutical-grade preparation for investigating retinoid pharmacology and dermatological pathways.
Laboratory Research Applications
This tretinoin formulation enables comprehensive investigation of retinoic acid receptor (RAR) and retinoid X receptor (RXX) signalling pathways in cellular models. Researchers examine tretinoin’s effects on keratinocyte differentiation, collagen synthesis modulation, and cellular proliferation mechanisms in controlled laboratory environments. The pharmaceutical preparation facilitates studies investigating retinoid-induced gene expression changes and their downstream effects on cellular metabolism. Scientists studying tretinoin compounds analyse dose-dependent responses in cell culture systems, examining how retinoid exposure influences cellular morphology and protein expression profiles. This research contributes to understanding vitamin A derivative mechanisms and their potential therapeutic applications in dermatological conditions.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Tretinoin 0.05% |
| Manufacturer | Johnson & Johnson |
| Formulation | Topical Cream |
| CAS Number | 302-79-4 |
| Storage | 15-25°C, protect from light |
Researchers also investigate other retinoid compounds alongside selective androgen receptor modulators and research peptides to understand complex cellular signalling interactions.
Regulatory Compliance Statement
Retino A 0.05% Cream is supplied exclusively for in-vitro laboratory research purposes. This pharmaceutical preparation is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must handle this compound according to institutional safety protocols and maintain appropriate documentation for research use only. All studies should comply with relevant laboratory guidelines and ethical research standards.
